Heparin is a promising agent for the treatment of endometriosis-associated fibrosis

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 46-51

  Nasu, Kaei ^a   Tsuno, Akitoshi ^a   Hirao, Marina ^a   Kobayashi, Hironao ^a   Yuge, Akitoshi ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

contractility; endometriosis; fibrosis; Heparin; Rho ROCK mediated pathway

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN FIBER; HEPARIN; PROTEIN KINASE; RHO ASSOCIATED COILED COIL FORMING PROTEIN KINASE I; RHO ASSOCIATED COILED COIL FORMING PROTEIN KINASE II; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG USE; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME ACTIVATION; FEMALE; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ADULT; ANIMALS; CATTLE; CELLS, CULTURED; COLLAGEN; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FIBROSIS; HEPARIN; HUMANS; STROMAL CELLS; SWINE;

EID: 77952553698     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.057     Document Type: Article

References (31)

1. Olive D.L., and Schwartz L.B. Endometriosis. N Engl J Med 328 (1993) 1759-1769
2. Nisolle M., and Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68 (1997) 585-596
3. Bonte H., Chapron C., Vieira M., Fauconnier A., Barakat H., Fritel X., et al. Histologic appearance of endometriosis infiltrating uterosacral ligaments in women with painful symptoms. J Am Assoc Gynecol Laparosc 9 (2002) 519-524
4. Itoga T., Matsumoto T., Takeuchi H., Yamasaki S., Sasahara N., Hoshi T., et al. Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int 53 (2003) 371-375
5. Matsuzaki S., Canis M., Darcha C., Dechelotte P., Pouly J.-L., and Bruhat M.A. Fibrogenesis in peritoneal endometriosis. Gynecol Obstet Invest 47 (1998) 197-199
6. Anaf V., Simon P., Fayt I., and Noel J.-C. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 15 (2000) 767-771
7. Stovall D.W., Anners J.A., and Halme J. Immunohistochemical detection of type I, III, and IV collagen in endometriotic implants. Fertil Steril 57 (1992) 984-989
8. Yuge A., Nasu K., Matsumoto H., Nishida M., and Narahara H. Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis. Hum Reprod 22 (2007) 938-944
9. Nasu K., Yuge A., Tsuno A., Matsumoto H., and Narahara H. Ras homology (Rho)/Rho-associated coiled-coil-forming protein kinase (ROCK)-mediated signaling pathway in endometriosis-associated fibrosis. Res Adv Hum Reprod 1 (2008) 1-9
10. Hirsh J., Raschke R., Warrkentin T.E., Dalen J.E., Deykin D., and Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108 (1995) 258-275
11. Becker R.C. Optimizing heparin compounds: a working construct for future antithrombotic drug development. J Thromb Thrombolysis 18 (2004) 55-58
12. Gettins P.G. Serpin structure, mechanism, and function. Chem Rev 102 (2002) 4751-4803
13. Dementiev A., Petitou M., Herbert J.-M., and Gettins P.G. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity. Nat Struct Biol 11 (2004) 867-3
14. Li W., Johnson D.J., Esmon C.T., and Huntington J.A. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 11 (2004) 857-862
15. Guidry C., and Grinnell F. Heparin modulates the organization of hydrated collagen gels and inhibits gel contraction by fibroblasts. J Cell Biol 104 (1987) 1097-1103
16. Schaefer T., Roux M., Stuhlsatz H.W., Herken R., Coulomb B., Krieg T., et al. Glycosaminoglycans modulate cell-matrix interactions of human fibroblasts and endothelial cells in vitro. J Cell Sci 109 (1996) 479-488
17. Worth N.F., Campbell G.R., Campbell J.H., and Rolfe B.E. Rho expression and activation in vascular smooth muscle cells. Cell Motil Cytoskeleton 59 (2004) 189-200
18. Nishida M., Nasu K., Fukuda J., Kawano Y., Narahara H., and Miyakawa I. Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J Clin Endocrinol Metab 89 (2004) 5094-5100
19. Matsumoto H., Nasu K., Nishida M., Ito H., Bing S., and Miyakawa I. Regulation of proliferation, motility, and contractility of human endometrial stromal cells by platelet-derived growth factor. J Clin Endocrinol Metab 90 (2005) 3560-3567
20. Baird A., and Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142 (1987) 428-435
21. lodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., et al. Endothelial cell-derived basic fibroblast growth factor synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84 (1987) 2292-2296
22. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., and Vlodavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130 (1988) 393-400
23. Dubertret L., Brunner-Ferber F., Misiti J., Thomas K.A., and Dubertret M.-L. Activities of human acidic fibroblast growth factor in an in vitro dermal equivalent model. J Invest Dermatol 97 (1991) 793-798
24. Imaizumi T., Jean-Louis F., Dubertret M.-L., Bailly C., Cicurel L., Petchot-Bacque J.-P., et al. Effect of human basic fibroblast growth factor on fibroblast proliferation, cell volume, collagen lattice contraction: in comparison with acidic type. J Dermatol Sci 11 (1996) 134-141
25. Gospodarowcz D., and Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128 (1986) 475-484
26. Lobb R.R. Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 27 (1988) 2568-2572
27. Rosengart T.K., Johnson W.V., Friesel R., Clark R., and Maciag T. Heparin protects heparin-binding growth factor-1 from proteolytic inactivation in vitro. Biochem Biophys Res Commun 152 (1988) 432-440
28. Damon D.H., Lobb R.R., D'Amore P.A., and Wagner J.A. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J Cell Physiol 138 (1989) 221-226
29. Mueller S., Thomas K.A., DiSalvo J., and Levine E.M. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vivo. J Cell Physiol 138 (1989) 439-448
30. Grinnell F. Fibroblast-collagen-matrix contraction: growth factor signaling and mechanical loading. Trends Cell Biol 10 (2000) 362-365
31. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12 (2001) 2730-2741